{"title":"IFT122 Regulates Proliferation of mEPMCs Through the Shh Signaling Pathway by Primary Cilia.","authors":"Ruoyu Mei, Jianan Guo, Jie Yin, Wei He, Fang Wang","doi":"10.1177/10556656251352294","DOIUrl":null,"url":null,"abstract":"<p><p>ObjectiveTo investigate how intraflagellar transport protein 122 (IFT122) regulates murine embryonic palate mesenchymal cell (mEPMC) proliferation via the Sonic Hedgehog (Shh) pathway and its dependency on primary cilia integrity, elucidating mechanisms underlying cleft palate pathogenesis.DesignIntraflagellar transport protein 122 was silenced in E14.5-derived mEPMCs using lentiviral shRNA. Primary cilia morphology (immunofluorescence), Shh signaling components (Smo, Gli3 via qPCR/Western blot), and proliferation markers (CCK-8 assay, Proliferating Cell Nuclear Antigen [PCNA], Cyclin D1) were analyzed. Rescue experiments employed the Smoothened agonist (SAG) to activate Shh signaling.Main Outcome MeasureCilia incidence and length; Smo/Gli3 mRNA and protein expression; Gli3A/Gli3R ratio; cell proliferation rates (OD values, PCNA, Cyclin D1); SAG-mediated rescue effects.ResultsIntraflagellar transport protein 122 knockdown reduced cilia incidence (10.2% vs 2.4%, <i>P</i> < .01) and length (7.8 μm vs 3.4 μm, <i>P</i> < .01), impaired Smo trafficking (mRNA↓42%, protein↓50%), suppressed Gli3A/Gli3R ratio (↓62%), and inhibited proliferation (PCNA/Cyclin D1↓40%-60%, <i>P</i> < .01). Smoothened agonist partially restored Smo expression (↑1.8×), Gli3 activation, and proliferation (<i>P</i> < .05), confirming cilia-dependent Shh regulation.ConclusionIntraflagellar transport protein 122 maintains primary cilia structure to enable Shh-driven mEPMC proliferation. Its deficiency disrupts cilia integrity and Shh signaling, linking ciliary dysfunction to cleft palate. Partial rescue by SAG validates the mechanism, highlighting therapeutic potential for targeting cilia-Shh axis defects.</p>","PeriodicalId":49220,"journal":{"name":"Cleft Palate-Craniofacial Journal","volume":" ","pages":"10556656251352294"},"PeriodicalIF":1.1000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cleft Palate-Craniofacial Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10556656251352294","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Dentistry","Score":null,"Total":0}
引用次数: 0
Abstract
ObjectiveTo investigate how intraflagellar transport protein 122 (IFT122) regulates murine embryonic palate mesenchymal cell (mEPMC) proliferation via the Sonic Hedgehog (Shh) pathway and its dependency on primary cilia integrity, elucidating mechanisms underlying cleft palate pathogenesis.DesignIntraflagellar transport protein 122 was silenced in E14.5-derived mEPMCs using lentiviral shRNA. Primary cilia morphology (immunofluorescence), Shh signaling components (Smo, Gli3 via qPCR/Western blot), and proliferation markers (CCK-8 assay, Proliferating Cell Nuclear Antigen [PCNA], Cyclin D1) were analyzed. Rescue experiments employed the Smoothened agonist (SAG) to activate Shh signaling.Main Outcome MeasureCilia incidence and length; Smo/Gli3 mRNA and protein expression; Gli3A/Gli3R ratio; cell proliferation rates (OD values, PCNA, Cyclin D1); SAG-mediated rescue effects.ResultsIntraflagellar transport protein 122 knockdown reduced cilia incidence (10.2% vs 2.4%, P < .01) and length (7.8 μm vs 3.4 μm, P < .01), impaired Smo trafficking (mRNA↓42%, protein↓50%), suppressed Gli3A/Gli3R ratio (↓62%), and inhibited proliferation (PCNA/Cyclin D1↓40%-60%, P < .01). Smoothened agonist partially restored Smo expression (↑1.8×), Gli3 activation, and proliferation (P < .05), confirming cilia-dependent Shh regulation.ConclusionIntraflagellar transport protein 122 maintains primary cilia structure to enable Shh-driven mEPMC proliferation. Its deficiency disrupts cilia integrity and Shh signaling, linking ciliary dysfunction to cleft palate. Partial rescue by SAG validates the mechanism, highlighting therapeutic potential for targeting cilia-Shh axis defects.
目的研究纤束内转运蛋白122 (IFT122)通过Shh通路调控小鼠胚胎腭间充质细胞(mEPMC)增殖及其对原纤毛完整性的依赖性,揭示腭裂发病机制。设计用慢病毒shRNA在e14.5衍生的mepmc中沉默了鞭毛内转运蛋白122。分析初级纤毛形态(免疫荧光),Shh信号成分(Smo, Gli3通过qPCR/Western blot)和增殖标志物(CCK-8测定,增殖细胞核抗原[PCNA], Cyclin D1)。救援实验采用平滑激动剂(SAG)激活Shh信号。主要观察指标:纤毛发生率和长度;Smo/Gli3 mRNA及蛋白表达;Gli3A / Gli3R比率;细胞增殖率(OD值、PCNA、Cyclin D1);sag介导的拯救作用。结果鞭毛转运蛋白122敲低组纤毛发生率分别为10.2%和2.4%,P P P P
期刊介绍:
The Cleft Palate-Craniofacial Journal (CPCJ) is the premiere peer-reviewed, interdisciplinary, international journal dedicated to current research on etiology, prevention, diagnosis, and treatment in all areas pertaining to craniofacial anomalies. CPCJ reports on basic science and clinical research aimed at better elucidating the pathogenesis, pathology, and optimal methods of treatment of cleft and craniofacial anomalies. The journal strives to foster communication and cooperation among professionals from all specialties.